A Phase IIa Trial Investigating the Safety, Tolerability, Pharmacokinetics and Efficacy of Topical Ointment YR001 in Adult Patients With Mild to Moderate Atopic Dermatitis

Conditions: Atopic Dermatitis Interventions: Drug: YR001 ointment Sponsors: Hangzhou Yirui Pharmaceutical Technology Co., Ltd Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials